Document is current
Any future updates will be listed below
-
Authors
,
von Siemens, Sarah Marietta
Jörres, Rudolf A.
Behr, Jürgen
Alter, Peter
Lutter, Johanna
Lucke, Tanja
Söhler, Sandra
Welte, Tobias
Watz, Henrik
Vogelmeier, Claus F.
Trudzinski, Franziska
Rief, Winfried
Herbig, Britta
Kahnert, Kathrin
-
Funding
Funding for this research was provided by:
German Federal Ministry of Education and Research (01 GI 0881)
AstraZeneca GmbH (not applicable)
Bayer Schering Pharma AG (not applicable)
Boehringer Ingelheim Pharma GmbH & Co. KG (not applicable)
Chiesi GmbH (not applicable)
GlaxoSmithKline (not applicable)
Grifols Deutschland GmbH (not applicable)
MSD Sharp & Dohme GmbH (not applicable)
Mundipharma GmbH (not applicable)
Novartis Deutschland GmbH (not applicable)
Pfizer Pharma GmbH (not applicable)
Takeda Pharma Vertrieb GmbH & Co (not applicable)
- License Information
-
More Information
Article History
Received: 17 December 2018
Accepted: 4 February 2019
First Online: 11 February 2019
Ethics approval and consent to participate
: All assessments were approved by the central (Marburg (Ethikkommission FB Medizin Marburg) and local (Bad Reichenhall (Ethikkommission bayerische Landesärztekammer); Berlin (Ethikkommission Ärztekammer Berlin); Bochum (Ethikkommission Medizinische Fakultät der RUB); Borstel (Ethikkommission Universität Lübeck); Coswig (Ethikkommission TU Dresden); Donaustauf (Ethikkommission Universitätsklinikum Regensburg); Essen (Ethikkommission Medizinische Fakultät Duisburg-Essen); Gießen (Ethikkommission Fachbereich Medizin); Greifswald (Ethikkommission Universitätsmedizin Greifswald); Großhansdorf (Ethikkommission Ärztekammer Schleswig-Holstein); Hamburg (Ethikkommission Ärztekammer Hamburg); MHH Hannover / Coppenbrügge (MHH Ethikkommission); Heidelberg Thorax/Uniklinik (Ethikkommission Universität Heidelberg); Homburg (Ethikkommission Saarbrücken); Immenhausen (Ethikkommission Landesärztekammer Hessen); Kiel (Ethikkommission Christian-Albrechts-Universität zu Kiel); Leipzig (Ethikkommission Universität Leipzig); Löwenstein (Ethikkommission Landesärztekammer Baden-Württemberg); Mainz (Ethikkommission Landesärztekammer Rheinland-Pfalz); München LMU/Gauting (Ethikkommission Klinikum Universität München); Nürnberg (Ethikkommission Friedrich-Alexander-Universität Erlangen Nürnberg); Rostock (Ethikkommission Universität Rostock); Berchtesgadener Land (Ethikkommission Land Salzburg); Schmallenberg (Ethikkommission Ärztekammer Westfalen-Lippe); Solingen (Ethikkommission Universität Witten-Herdecke); Ulm (Ethikkommission Universität Ulm); Würzburg (Ethikkommission Universität Würzburg)) ethical committees and written informed consent was obtained from all patients.The study was conducted from September 2011 to December 2013 and comprised 151 patients recruited within the COSYCONET framework (, Identifier: NCT01245933).For further information see:Karch A, Vogelmeier C, Welte T, Bals R, Kauczor HU, Biederer J, Heinrich J, Schulz H, Glaser S, Holle R et al.: The German COPD cohort COSYCONET: Aims, methods and descriptive analysis of the study population at baseline. Respir Med 2016, 114:27–37.
: Within the ethical approval the participants of the study gave their consent to publish the data collected during the study period.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
